"What Should I Do if I Have Her-23+ Breast Cancer?"

Breast cancer Her-2 3+ indicates that human epidermal growth factor receptor 2 is positive, belonging to low-amplified breast cancer, which requires targeted drug therapy to improve the condition. Low-amplified breast cancer indicates that breast epithelial cells have lost control of proliferation under the influence of various carcinogenic factors, which may be related to family inheritance and excessive changes in hormone levels. Patients usually have symptoms such as breast masses, nipple discharge, and enlarged axillary lymph nodes. Under the guidance of a doctor, patients can reasonably use trastuzumab for injection, pertuzumab for injection, pyrotinib maleate tablets, and other drugs to inhibit the growth and reproduction of tumor cells, thus preventing tumor metastasis or diffusion. These drugs have certain side effects, which may stimulate the digestive tract and easily cause nausea and vomiting. During treatment, it is necessary to regularly undergo relevant examinations at the hospital to clarify the changes in the body. If tumor cells further spread, standardized treatment should be carried out as early as possible to avoid delaying the best treatment time. It is important to learn to adjust one's emotions and not to give oneself too much psychological burden to avoid endocrine disorders.